Skip to main content
. 2017 Nov 3;10(1):129–142. doi: 10.1080/19420862.2017.1386824

Table 4.

Individual laboratory relative potency estimates (geometric mean) for ADCC assays.

    Versus IH Refb
Versus candidate (Sample A)
    Candidate (Sample A)
Sample C
Coded duplicate (Sample B)
Sample C
Methoda Lab GM %GCV n GM %GCV n GM %GCV n GM %GCV n
ADCC-R 1 0.85 26 5 0.95 25 6 0.96 30 9 1.06 23 7
ADCC-NK 6 1.28 21 6 1.39 20 7 1.00 13 8 1.11 15 7
ADCC-R 7 1.46 27 15 1.73 16 7 0.99 17 9 1.32 29 6
ADCC-R 8 0.94 7 5 1.17 7 9 1.01 7 9 1.25 7 9
ADCC-NK 10 0.44 21 9 0.64 15 9 0.91 18 9 1.44 25 9
ADCC-P 11 Not available 1.03 33 7 1.60 21 7
ADCC-R 12 2.17 n/a 2 2.42 13 6 1.00 20 6 1.06 22 5
ADCC-NK 13 0.75 10 9 1.13 14 9 0.99 10 9 1.50 8 9
ADCC-P 14 Not available 0.92 25 3 1.48 13 4
ADCC-P 15 0.78 32 8 0.92 36 8 0.86 20 7 1.17 35 7
ADCC-DR 16 Not available 0.93 12 7 1.26 15 6
a

ADCC-R and ADCC-DR indicate labs using a single or dual gene reporter assay, respectively and end-point killing based assays are shown as ADCC-NK and ADCC-P for assays using NK cell lines or primary cells, respectively; b

b

“In house” reference standard.